Does SELPERCATINIB Cause Pulmonary embolism? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Pulmonary embolism have been filed in association with SELPERCATINIB (RETEVMO). This represents 2.0% of all adverse event reports for SELPERCATINIB.
22
Reports of Pulmonary embolism with SELPERCATINIB
2.0%
of all SELPERCATINIB reports
2
Deaths
17
Hospitalizations
How Dangerous Is Pulmonary embolism From SELPERCATINIB?
Of the 22 reports, 2 (9.1%) resulted in death, 17 (77.3%) required hospitalization.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SELPERCATINIB. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does SELPERCATINIB Cause?
Malignant neoplasm progression (106)
Death (90)
Hypertension (58)
Hypersensitivity (55)
Diarrhoea (54)
Fatigue (51)
Rash (49)
Hepatic function abnormal (42)
Alanine aminotransferase increased (38)
Pyrexia (38)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which SELPERCATINIB Alternatives Have Lower Pulmonary embolism Risk?
SELPERCATINIB vs SELUMETINIB
SELPERCATINIB vs SEMAGLUTIDE
SELPERCATINIB vs SEMUSTINE
SELPERCATINIB vs SENNA LEAF
SELPERCATINIB vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B